Hopwood J J, Muller V, Harrison J R, Carey W F, Elliott H, Robertson E F, Pollard A C
Med J Aust. 1982 Mar 20;1(6):257-60.
We assessed lysosomal exohydrolase activities in homogenates of cultured skin fibroblasts and peripheral blood leucocytes of approximately 550 patients referred from throughout Australasia and suspected of having a mucopolysaccharidosis. Of these, 96 patients from 80 families were diagnosed as being homozygous deficient for a particular lysosomal enzyme activity. Clinical phenotype varied considerably within each of the enzyme-deficient states. This did not correlate with the level of "residual" enzyme activity in leucocyte or fibroblast homogenates. It was not always possible to discriminate heterozygotes from normal controls by enzyme assay of leucocyte or fibroblast homogenates in this study of a large number of mucopolysaccharidoses Type II by means of a single hair root assay system.
我们评估了来自澳大利亚和新西兰各地约550例疑似患有黏多糖贮积症患者的培养皮肤成纤维细胞和外周血白细胞匀浆中的溶酶体外切酶活性。其中,来自80个家庭的96例患者被诊断为特定溶酶体酶活性纯合缺陷。在每种酶缺乏状态下,临床表型差异很大。这与白细胞或成纤维细胞匀浆中“残余”酶活性水平无关。在这项通过单一毛囊检测系统对大量II型黏多糖贮积症进行的研究中,通过白细胞或成纤维细胞匀浆的酶检测,并不总是能够区分杂合子和正常对照。